Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic
暂无分享,去创建一个
Monica L. Miller | S. Antoniou | E. Schellhase | P. Wright | S. Fhadil | Mital Patel | Madeline Stanko | Natalie Kinstler
[1] V. Paudyal,et al. Interventions and Impact of Pharmacist-Delivered Services for People Infected with COVID-19: A Systematic Review , 2022, Healthcare.
[2] J. Robson,et al. Pharmacist-led multidisciplinary approach in preventing strokes in people with atrial fibrillation , 2022, European Journal of Cardiovascular Nursing.
[3] Xingming Cai,et al. Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis , 2021, Frontiers in Cardiovascular Medicine.
[4] Xiaoxi Yao,et al. Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. , 2019, Circulation.
[5] S. Antoniou,et al. Preventing strokes in people with atrial fibrillation by improving ABC , 2019, BMJ open quality.
[6] D. Atar,et al. Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1. , 2019, European heart journal.
[7] F. Gaita,et al. Subclinical and Asymptomatic Atrial Fibrillation: Current Evidence and Unsolved Questions in Clinical Practice , 2019, Medicina.
[8] Calvin E. Hwang. Calculated Decisions: HAS-BLED Score for Major Bleeding Risk , 2019, Emergency medicine practice.
[9] Hugh Calkins,et al. Correction to: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2019, Circulation.
[10] Hugh Calkins,et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2019, Heart rhythm.
[11] Hugh Calkins,et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2019, Journal of the American College of Cardiology.
[12] P. Noseworthy,et al. Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation. , 2017, The American journal of cardiology.
[13] D. Stewart,et al. Optimizing the use of oral anticoagulant therapy for atrial fibrilation in primary care: a pharmacist-led intervention , 2017, International Journal of Clinical Pharmacy.
[14] Emily P Zeitler,et al. Remote monitoring of cardiac implantable electronic devices (CIED). , 2016, Trends in cardiovascular medicine.
[15] J. Piccini,et al. Preventing Stroke in Patients With Atrial Fibrillation-A Steep Climb Away From Achieving Peak Performance. , 2016, JAMA cardiology.
[16] P. Kirchhof,et al. Primary Care Atrial Fibrillation Service: outcomes from consultant-led anticoagulation assessment clinics in the primary care setting in the UK , 2015, BMJ Open.
[17] P. Gorelick,et al. HRS/NSA 2014 Survey of Atrial Fibrillation and Stroke: Gaps in Knowledge and Perspective, Opportunities for Improvement. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[18] G. Lip,et al. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort. , 2015, The British journal of general practice : the journal of the Royal College of General Practitioners.
[19] D. Singer,et al. Risks and Benefits of Anticoagulation in Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry , 2013, Circulation. Cardiovascular quality and outcomes.
[20] M. Fang,et al. Assessing bleeding risk in patients taking anticoagulants , 2013, Journal of Thrombosis and Thrombolysis.
[21] K. Furie,et al. Statin Therapy and Outcome After Ischemic Stroke: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials , 2013, Stroke.
[22] Kelly M. Rudd,et al. Comparison of Two Different Models of Anticoagulation Management Services with Usual Medical Care , 2010, Pharmacotherapy.
[23] S. Lakhan,et al. Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis , 2009, International archives of medicine.
[24] Chunliu Zhan,et al. Cardiac Device Implantation in the United States from 1997 through 2004: A Population-based Analysis , 2007, Journal of General Internal Medicine.
[25] L. Till,et al. Assessment of Clinical Pharmacist Management of Lipid-Lowering Therapy in a Primary Care Setting , 2003, Journal of managed care pharmacy : JMCP.
[26] E. Vivian. Improving Blood Pressure Control in a Pharmacist‐Managed Hypertension Clinic , 2002, Pharmacotherapy.
[27] Guy E. Thwaites,et al. The Diagnosis and Management of Tuberculous Meningitis , 2002, Practical Neurology.